Alyeska Investment Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,416
| Closed | -$6.61M | – | 559 |
|
|
2025
Q1 | $6.61M | Sell |
42,416
-112,584
| -73% | -$17.5M | 0.03% | 342 |
|
|
2024
Q4 | $21.3M | Buy |
155,000
+40,000
| +35% | +$5.51M | 0.08% | 249 |
|
|
2024
Q3 | $17.2M | Buy |
115,000
+55,000
| +92% | +$8.21M | 0.09% | 248 |
|
|
2024
Q2 | $8.18M | Buy |
+60,000
| New | +$8.18M | 0.05% | 290 |
|
|
2023
Q4 | – | Sell |
-112,994
| Closed | -$10.6M | – | 439 |
|
|
2023
Q3 | $10.6M | Buy |
112,994
+67,994
| +151% | +$6.37M | 0.07% | 269 |
|
|
2023
Q2 | $4.02M | Hold |
45,000
| – | – | 0.03% | 339 |
|
|
2023
Q1 | $4.82M | Buy |
+45,000
| New | +$4.82M | 0.04% | 297 |
|
|
2019
Q3 | – | Sell |
-39,101
| Closed | -$4.5M | – | 364 |
|
|
2019
Q2 | $4.5M | Sell |
39,101
-16,777
| -30% | -$1.93M | 0.06% | 234 |
|
|
2019
Q1 | $6.58M | Buy |
+55,878
| New | +$6.58M | 0.09% | 188 |
|
|
2018
Q4 | – | Sell |
-9,000
| Closed | -$638K | – | 318 |
|
|
2018
Q3 | $638K | Sell |
9,000
-28,190
| -76% | -$2M | 0.01% | 340 |
|
|
2018
Q2 | $2.47M | Buy |
37,190
+10,490
| +39% | +$698K | 0.02% | 315 |
|
|
2018
Q1 | $1.75M | Sell |
26,700
-59,800
| -69% | -$3.91M | 0.01% | 331 |
|
|
2017
Q4 | $3.47M | Sell |
86,500
-23,500
| -21% | -$941K | 0.03% | 261 |
|
|
2017
Q3 | $3.99M | Buy |
+110,000
| New | +$3.99M | 0.03% | 290 |
|
|
2015
Q4 | – | Sell |
-67,079
| Closed | -$1.19M | – | 365 |
|
|
2015
Q3 | $1.19M | Buy |
67,079
+6,139
| +10% | +$109K | 0.01% | 370 |
|
|
2015
Q2 | $1.08M | Sell |
60,940
-39,015
| -39% | -$690K | 0.01% | 381 |
|
|
2015
Q1 | $1.73M | Buy |
+99,955
| New | +$1.73M | 0.02% | 359 |
|